Christopher A Berger
Biographic Data
| ID | 9064142 |
|---|---|
| NAME | Christopher A Berger |
| GIVEN NAMES | Christopher A |
| FAMILY NAME | Berger |
| SIGNATURE | BERGER C A |
| AFFILIATIONS | San Francisco General Hospital |
| ORCID | 0000-0002-0034-7544 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP delivery. We conducted a qualitative assessment of 3HP delivery nested within the 3HP Options Trial, which compared three optimized strategies for delivering 3HP: facilitated directly observed therapy (DOT…
No prominent works on this page.
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP delivery. We conducted a qualitative assessment of 3HP delivery nested within the 3HP Options Trial, which compared three optimized strategies for delivering 3HP: facilitated directly observed therapy (DOT…
Dosing (1 works) · Family medicine (1 works) · Internal Medicine (1 works) · Latent tuberculosis (1 works) · Medicine (1 works) · Pneumocystis jirovecii pneumonia detection and treatment (1 works) · Pneumonia and Respiratory Infections (1 works) · Qualitative research (1 works) · Rifapentine (1 works) · Thematic analysis (1 works)